Dongbang Medical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	108,309	105,114	90,875	81,408
Revenue Growth (YoY)	10.08%	15.67%	11.63%	-
Cost of Revenue	72,082	71,020	60,134	58,887
Gross Profit	36,227	34,094	30,741	22,520
Selling, General & Admin	16,702	14,821	11,972	11,240
Research & Development	2,806	2,591	2,100	1,798
Other Operating Expenses	418.43	361.01	286.9	572.2
Operating Expenses	21,235	18,618	13,560	16,961
Operating Income	14,992	15,476	17,182	5,560
Interest Expense	-1,440	-1,956	-2,613	-1,308
Interest & Investment Income	297.92	201.48	86.23	40.72
Earnings From Equity Investments	-	-	45.53	-
Currency Exchange Gain (Loss)	-104.24	1,080	-202.05	734.38
Other Non Operating Income (Expenses)	-529.14	-9,270	-1,182	1,159
EBT Excluding Unusual Items	13,216	5,532	13,317	6,186
Gain (Loss) on Sale of Investments	-1,184	-727.67	-709.31	-537.95
Gain (Loss) on Sale of Assets	259.64	1,986	-102.65	-28.47
Pretax Income	12,291	6,791	12,505	5,619
Income Tax Expense	2,937	3,663	2,771	2,300
Earnings From Continuing Operations	9,354	3,127	9,734	3,320
Minority Interest in Earnings	-25.17	-212.84	40.46	-127.95
Net Income	9,329	2,914	9,775	3,192
Net Income to Common	9,329	2,914	9,775	3,192
Net Income Growth	223.75%	-70.19%	206.26%	-
Shares Outstanding (Basic)	18	16	15	15
Shares Outstanding (Diluted)	18	16	17	15
Shares Change (YoY)	6.06%	-7.51%	17.90%	-
EPS (Basic)	509.74	180.07	658.62	215.05
EPS (Diluted)	509.74	180.07	617.82	215.05
EPS Growth	171.42%	-70.85%	187.29%	-
Free Cash Flow	-1,055	5,408	1,811	4,379
Free Cash Flow Per Share	-57.16	334.19	103.53	295.08
Gross Margin	33.45%	32.44%	33.83%	27.66%
Operating Margin	13.84%	14.72%	18.91%	6.83%
Profit Margin	8.61%	2.77%	10.76%	3.92%
Free Cash Flow Margin	-0.97%	5.15%	1.99%	5.38%
EBITDA	21,638	21,640	22,630	10,832
EBITDA Margin	19.98%	20.59%	24.90%	13.31%
D&A For EBITDA	6,646	6,164	5,448	5,272
EBIT	14,992	15,476	17,182	5,560
EBIT Margin	13.84%	14.72%	18.91%	6.83%
Effective Tax Rate	23.90%	53.95%	22.16%	40.92%
Advertising Expenses	-	1,446	994.74	482.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.